FDA inspection

Camfield Plant, Kivipharm Co., Ltd.: FDA inspection ending Jun 14, 2024

FDA inspection 1243738 · No Action Indicated (NAI) · Zhangjiakou

Key facts

Inspection ID 1243738
Firm Camfield Plant, Kivipharm Co., Ltd.
FEI number 3015844794
Address Building 26, 88 Shengli South Road; Technical Development Zone
City Zhangjiakou
Fiscal year 2024
Inspection end date Jun 14, 2024
Classification No Action Indicated (NAI)
Project area Generic Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections